Virpax Pharmaceuticals, Inc.
USD0.01
+0.00 (+0.00%)
CEO
Jatinder Dhaliwal
IPO Date
2021-02-17
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.02
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.02
52W Low
$0.00
52W High
$0.46
Market Cap
$0.00B
Volume
0.00M
| -6.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -129.4% | -109.1% | 0.00 | 6.36 | -8.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -32.4% | -30.7% | 0.00 | 18.96 | -82.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 106.4% | -964.2% | -0.37 | 0.02 | -179.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 125.6% | -7344.2% | -0.46 | 0.02 | -248.1 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 221.4% | -4294.2% | -0.42 | 0.05 | -3056.9 |
| -10.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 123.5% | -133.2% | 0.00 | 0.48 | -1.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 265.4% | -102.9% | 0.00 | 0.72 | -9.6 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -235.8% | -47.4% | 0.00 | 1.25 | -5.1 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -92.1% | -46.0% | 0.00 | 2.00 | -9.8 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -25.3% | -19.5% | 0.00 | 4.37 | -25.4 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -9.1% | -7.5% | 0.00 | 5.61 | -41.3 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -17.3% | -14.6% | 0.00 | 6.36 | -15.9 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -39.0% | -32.0% | 0.00 | 5.62 | -115.1 |